ProceduresGovernment

Amino-Aldehydes, Amino-Ketones and Amino-Quinones; Salts Thereof (Excl. those Containing Different Oxygenated Functions, as well as Amfepramone "Inn", Methadone "Inn", Normethadone "Inn" and its Salts)

Código 292239 (Harmonized System 2012 by 6 digits)

 2023: US$3.13M, Total Trade Exchange

2023: US$404k, International Sales

  2023: US$2.73M, International Purchases

In 2023, the trade exchange (includes international purchases and sales) of Amino-Aldehydes, Amino-Ketones and Amino-Quinones; Salts Thereof (Excl. those Containing Different Oxygenated Functions, as well as Amfepramone "Inn", Methadone "Inn", Normethadone "Inn" and its Salts) was US$3.13M.

The states with the most international purchases in 2023 were Jalisco (US$1.95M), Ciudad de México (US$691k), Estado de México (US$21.1k), and Sonora (US$7.42k).

The main commercial origins of Amino-Aldehydes, Amino-Ketones and Amino-Quinones; Salts Thereof (Excl. those Containing Different Oxygenated Functions, as well as Amfepramone "Inn", Methadone "Inn", Normethadone "Inn" and its Salts) in 2023 were China (US$1.37M), India (US$1.26M), Germany (US$20.6k), Italy (US$8.55k), and United States (US$7.42k).

In the global context, the main exporting countries of Amino-Aldehydes, Amino-Ketones and Amino-Quinones; Salts Thereof (Excl. those Containing Different Oxygenated Functions, as well as Amfepramone "Inn", Methadone "Inn", Normethadone "Inn" and its Salts) in 2022 were China (US$60.9M), India (US$47.7M), and Italy (US$21.5M). In the same year, the main importing countries of Amino-Aldehydes, Amino-Ketones and Amino-Quinones; Salts Thereof (Excl. those Containing Different Oxygenated Functions, as well as Amfepramone "Inn", Methadone "Inn", Normethadone "Inn" and its Salts) were United States (US$19.1M), India (US$16.7M), and Canada (US$16.1M).

Trade Balance of Mexico

#permalink to section

Net Trade Balance

#permalink to section

US$3.13M, Total Trade Exchange (2023)

In 2023, the total trade exchange of Amino-Aldehydes, Amino-Ketones and Amino-Quinones; Salts Thereof (Excl. those Containing Different Oxygenated Functions, as well as Amfepramone "Inn", Methadone "Inn", Normethadone "Inn" and its Salts) in Mexico (including international purchases and sales) was US$3.13M.

The visualizations show the net balance of Amino-Aldehydes, Amino-Ketones and Amino-Quinones; Salts Thereof (Excl. those Containing Different Oxygenated Functions, as well as Amfepramone "Inn", Methadone "Inn", Normethadone "Inn" and its Salts) at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.

Net International Trade

#permalink to section

July, 2024: US$5.32k, International Purchases

In July 2024, international sales of Amino-Aldehydes, Amino-Ketones and Amino-Quinones; Salts Thereof (Excl. those Containing Different Oxygenated Functions, as well as Amfepramone "Inn", Methadone "Inn", Normethadone "Inn" and its Salts) were US$0, while international purchases reached US$5.32k. The above results in a trade balance of -US$5.32k.

Exchange by Territory

#permalink to section

International Purchases

#permalink to section

Jalisco: US$1.95M, State with the Most International Purchases (2023)

China: US$1.37M, Main Commercial Origin (2023)

In 2023, the states with the highest international in Amino-Aldehydes, Amino-Ketones and Amino-Quinones; Salts Thereof (Excl. those Containing Different Oxygenated Functions, as well as Amfepramone "Inn", Methadone "Inn", Normethadone "Inn" and its Salts) were Jalisco (US$1.95M), Ciudad de México (US$691k), Estado de México (US$21.1k), and Sonora (US$7.42k).

The countries with the most international sales to Mexico in 2023 were China (US$1.37M), India (US$1.26M), Germany (US$20.6k), Italy (US$8.55k), and United States (US$7.42k).

Specialization

#permalink to section

Specialization by State

#permalink to section

The RCA-Complexity  diagram compares the Revelead Comparative Advantages of states in Amino-Aldehydes, Amino-Ketones and Amino-Quinones; Salts Thereof (Excl. those Containing Different Oxygenated Functions, as well as Amfepramone "Inn", Methadone "Inn", Normethadone "Inn" and its Salts)  and the Economic Complexity Index of each state.

RCA values ​​greater than 1 indicate that the state has comparative advantages in Amino-Aldehydes, Amino-Ketones and Amino-Quinones; Salts Thereof (Excl. those Containing Different Oxygenated Functions, as well as Amfepramone "Inn", Methadone "Inn", Normethadone "Inn" and its Salts). On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.

Origins and Trade Destinations

#permalink to section

  • 0.3%, Mexican share in global exports - 2022
  • 1.12%, Mexican share in global imports - 2022

The visualizations show the global market for Amino-Aldehydes, Amino-Ketones and Amino-Quinones; Salts Thereof (Excl. those Containing Different Oxygenated Functions, as well as Amfepramone "Inn", Methadone "Inn", Normethadone "Inn" and its Salts). In both charts, Mexico stands out in order to identify its participation in the export and import market.

In 2022, the main exporting countries of Amino-Aldehydes, Amino-Ketones and Amino-Quinones; Salts Thereof (Excl. those Containing Different Oxygenated Functions, as well as Amfepramone "Inn", Methadone "Inn", Normethadone "Inn" and its Salts) were China (US$60.9M), India (US$47.7M), and Italy (US$21.5M). In the same year, the main importing countries for Amino-Aldehydes, Amino-Ketones and Amino-Quinones; Salts Thereof (Excl. those Containing Different Oxygenated Functions, as well as Amfepramone "Inn", Methadone "Inn", Normethadone "Inn" and its Salts) were United States (US$19.1M), India (US$16.7M), and Canada (US$16.1M).